20506 ⎘
Medicinal preparations containing organic active ingredients; Phosphorus compounds; Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
Medical intervention in haematological cancers
#902Compositions for Enhancing the Production of PPAR and/or PPAR-Associated Factors
#903Concentrated therapeutic phospholipid compositions
#904CRYSTALLINE PHOSPHOLIPID, METHOD FOR ITS PRODUCTION AND USE IN TREATING DAMAGED TISSUE
#905Dissolvable dietary supplement strip and methods for using the same
#906Glycerophospholipids for the improvement of cognitive functions
#907Ophthalmic device, and method of use thereof, for increasing ocular boundary lubrication
#908PHARMACEUTICAL COMPOSITION BASED ON MICRONIZED PROGESTERONE, PREPARATION METHOD AND USES THEREOF
#909Method for preparation of polyunsaturated fatty acid-containing phosphatidylserine
#910Oral Dosage Form Comprising Tri-Substituted Glycerol Compounds
#911Stimulation of an immune response by enantiomers of cationic lipids
#912COMPOSITIONS FOR USE IN TREATING OR PREVENTING METABOLIC STRESS-INDUCED LUNG INJURY AND METHODS FOR INCREASING PHYSICAL CAPACITY OF MAMMALIAN LIVESTOCK
#913HEALING POWDER AND METHOD OF USE THEREOF
#914Cosmetic composition and method for retarding hair growth
#915COMPOSITIONS COMPRISING PHOSPHOLIPIDS
#916Compositions and methods of treatment for alleviating premenstrual syndrome symptoms
#917Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
#918NOVOBIOCIN ANALOGUES AND TREATMENT OF POLYCYSTIC KIDNEY DISEASE
#919Methods of making compositions comprising lecithin oils and NSAIDS for protecting the gastrointestinal tract and providing enhanced therapeutic activity
#920Therapeutic modulation of ocular surface lubrication
#921Methods of treating inflammation with compositions comprising lecithin oils and NSAIDS for protecting the gastrointestinal tract and providing enhanced therapeutic activity
#922NOVEL LEUKOTRIENE RECEPTOR AGONIST
#923NON-RADIOACTIVE PHOSPHOLIPID COMPOUNDS, COMPOSITIONS, AND METHODS OF USE
#924Compositions for treating dry eye disease
#925CHARGED PHOSPHOLIPID COMPOSITIONS AND METHODS FOR THEIR USE
#926COMPOSITION, FORMULATIONS & KIT FOR TREATMENT OF RESPIRATORY AND LUNG DISEASE WITH DEHYDROEPIANDROSTERONE(S) STEROID & AN ANTI-MUSCARINIC AGENT(S)
#927Anti-inflammatory compositions for treating brain inflammation
#928Compositions comprising lecithin oils and NSAIDs for protecting the gastrointestinal tract and providing enhanced therapeutic activity
#929WALNUT EXTRACTS FOR NUTRACEUTICAL APPLICATIONS
#930Use of alkylphosphocholines in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals
#931SUPPORTING ACETYLCHOLINE FUNCTION
#932PREVENTION AND TREATMENT OF ISCHEMIA-REPERFUSION INJURY AND RELATED CONDITIONS
#933Composition and method for promoting survival of aged basal forebrain cholinergic neuron leading to provention and treatment of age-related neurodegenerative disorder
#934METHODS AND RELATED COMPOSITIONS FOR REDUCTION OF FAT
#935Modulation of the Phospholipase A2 Pathway as a Therapeutic
#936Respiratory dispersion for metered dose inhalers comprising perforated microstructures
#937Anti-inflammatory properties of marine lipid compositions
#938Pharmaceutical formulation containing choline alfoscerate
#939Preparation for the prevention and/or treatment of vascular disorders
#940Lipid mixture for infant nutrition
#941Methods and Related Compositions for Reduction of Fat and Skin Tightening
#942Pharmaceutical Composition for Treatment or Prevention of Liver Cancer
#943ANTI-INFLAMMATORY COMPOSITION CONTAINING DOCOSAHEXAENOYL LYSOPHOSPHATIDYLAMINE AS AN ACTIVE INGREDIENT
#944Combination of unsaponifiable lipids combined with polyphenols and/or catechins for the protection, treatment and repair of cartilage in joints of humans and animals
#945Phospholipids for the Treatment of Infection by Togaviruses, Herpes Viruses and Coronaviruses
#946Formulations for the oral administration of therapeutic agents and related methods
#947Pulmonary delivery particles comprising an active agent
#948Molecular delivery vehicle
#949TREATMENT OF METABOLIC DISEASE
#950Cholesterol level lowering liposomes
#951Use of an endogenous ligand for peroxisome proliferator activated receptor alpha to treat liver disorders
#952Immunostimulant Composition Comprising At Least One Toll-Like Receptor 7 Or Toll-Like Receptor 8 Agonist And A Toll-Like Receptor 4 Agonist
#953Compositions for elastogenesis and connective tissue treatment
#954PHARMACEUTICAL COMPOSITIONS FOR THE ADMINISTRATION OF APTAMERS
#955Methods for promoting cellular health and treatment of cancer
#956Phospholipid and protein tablets
#957Tissue kallikrein for the treatment of diseases associated with amyloid protein
#958Compositions for enhancing the production of PPAR and/or PPAR-associated factors
#959Emulsified Composition
#960Substrate reduction therapy
#961Therapeutics for Cancer Using 3-Bromopyruvate and Other Selective Inhibitors of ATP Production
#962FOODSTUFF COMPOSITION TO IMPROVE DIGESTIBILITY OF FOODSTUFF LIPIDS
#963Use of perifosine in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals
#964Use of perifosine in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals
#965Carbohydrate-lipid constructs and their use in preventing or treating viral infection
#966Nanoparticle comprising rapamycin and albumin as anticancer agent
#967Topical dosage form comprising tri-substituted glycerol compounds
#968Oleyl phosphocholine
#969Method for alleviating pain using sphingosine-1-phosphate and related compounds, and assays for identifying such compounds
#970Ophthalmic composition
#971Use of Tri-Substituted Glycerol Compounds for the Treatment of Hematological Malignancies
#972Methods for joint lubrication and cartilage wear prevention making use of glycerophospholipids
#973Use of lipid conjugates in the treatment of conjunctivitis
#974COMPOSITION COMPRISING AT LEAST ONE PPAR AGONIST AND A LIPID COMPONENT
#975Lipids containing omega-3 and omega-6 fatty acids
#976COMPOSITIONS AND METHODS TO REDUCE FAT AND RETRACT SKIN
#977Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders
#978USE OF PHOSPHOLIPIDS FOR WOUND HEALING
#979TREATMENT FOR DARK ADAPTATION
#980Method to Reduce Oxidative Damage and Improve Mitochondrial Efficiency
#981METHODS FOR IMPROVING FRONTAL BRAIN BIOENERGETIC METABOLISM
#982METHODS FOR ATTENUATING ALLERGEN-INDUCED AIRWAY HYPERREACTIVITY USING CD1D DEPENDENT ANTAGONISTS
#983USE OF SUBSTITUTED GLYCERIN DERIVATIVES FOR PRODUCING A PHARMACEUTICAL PREPARATION
#984EPITOPE REDUCTION THERAPY
#985COMBINATION THERAPY FOR MODULATION OF ACTIVITY AND DEVELOPMENT OF CELLS AND TISSUES
#986COMPOSITIONS AND METHODS FOR THE PREVENTION OF CARDIOVASCULAR DISEASE
#987Anti-Inflammatory and Anti-Allergy Extracts from Nettle
#988Medicinal lipolysis of accumulation of fat
#989Multi-carotenoids compositions and methods
#990Medicinal targeted local lipolysis
#991Saposin C-DOPS: a novel anti-tumor agent
#992Nanoparticle-stabilized capsule formulation for treatment of inflammation
#993COMPOSITION, FORMULATIONS AND KIT FOR TREATMENT OF RESPIRATORY AND LUNG DISEASE WITH NON-GLUCOCORTICOID STEROIDS AND/OR UBIQUINONE AND A BRONCHODILATING AGENT
#994Esterified fatty acid composition
#995COMBINED TARGETED THERAPY FOR THE TREATMENT OF PROLIFERATIVE DISEASE
#996Multi-carotenoids compositions and uses therefor
#997Compositions and Methods for Fat Reduction
#998Therapeutic micro nutrient composition for lipolysis and sclerosis
#999COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF FIBROTIC, INFLAMMATORY AND NEOVASCULARIZATION CONDITIONS
#1000Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
#1001Methods for limiting spread of pulmonary infections
#1002Use of compounds of formula A-R-Xo pharmaceutically acceptable salts thereof for producing a pharmaceutically preparations
#1003COMBINATION COMPRISING SQUALENE, A PHOSPHOLIPID AND AN OMEGA 3 FATTY ACID FOR THE TREATMENT OF CANCER
#1004Methods using phosphatidylserine, lysophosphatidylserine, and/or salts thereof to increase testosterone levels
#1005Anti-inflammatory extract and agent and method for the production thereof
#1006Therapeutic micro nutrient composition for drug delivery
#1007Phospholipid complexes of curcumin having improved bioavailability
#1008MIXTURES OF AND METHODS OF USE FOR POLYUNSATURATED FATTY ACID-CONTAINING PHOSPHOLIPIDS AND ALKYL ETHER PHOSPHOLIPIDS SPECIES
#1009Systems and Methods For Determination of Compounds for Stimulation or Inhibition of Neocalcification
#1010Pharmaceutical composition based on micronized progesterone, preparation method and uses thereof
#1011Compositions and methods of using lamellar bodies for modifying linear biological macromolecules
#1012Methods and compositions related to PLUNC surfactant polypeptides
#1013METHOD FOR REDUCING THE SEVERITY OF NEUROLOGICAL DISORDERS
#1014Method for reducing the severity of neurological disorders
#1015Glycerophospholipids for the improvement of cognitive functions
#1016METHOD FOR MAKING KRILL MEAL
#1017Phospholipids for Use in the Treatment of an Allergic Inflammatory Condition
#1018Structured Phospholipids
#1019Composition for reducing the exudation of serum proteins
#1020NOVEL USE OF LIGANDS SPECIFIC TO FEX-2 POLYPEPTIDE
#1021Use of Surfactant Preparations for the Treatment of Surgical Adhesions
#1022TOPICAL COMPOSITION FOR TREATING PAIN
#1023TOPICAL COMPOSITION FOR TREATING PAIN
#1024TOPICIAL COMPOSITION FOR TREATING PAIN
#1025Topical composition for treating pain
#1026Treatment of Ibd and Ibs Using Both Probiotic Bacteria and Fermented Cereal as Treatment Effectors
#1027Lipid analogs for combating tumors
#1028CHARGED PHOSPHOLIPID COMPOSITIONS AND METHODS FOR THEIR USE
#1029Bioeffective krill oil compositions
#1030Method of treating dyslipidemic disorder
#1031Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders
#1032Method of Attenuating Reactions to Skin Irritants
#1033Methods and compositions for treating symptomes of diseases related to imbalance of essential fatty acids
#1034Compounds and methods for promoting cellular health and treatment of cancer
#1035TARGETED DELIVERY AND EXPRESSION OF PROCOAGULANT HEMOSTATIC ACTIVITY
#1036Dispersion for pulmonary delivery of a bioactive agent
#1037Methods and apparatus for creating particle derivatives of HDL with reduced lipid content
#1038Respiratory dispersion for metered dose inhalers
#1039Composition and Treatment Methods for Coronary Artery Disease
#1040Preparation for the prevention and/or treatment of vascular disorders
#1041Composition for protection and improvement of skin, or reinforcing skin barrier function comprising phosphatidylserine
#1042OINTMENT FOR CANCER TREATMENT
#1043Combination of unsaponifiable lipids combined with polyphenols and/or catechins for the protection, treatment and repair of cartilage in joints of humans and animals
#1044Use of therapeutically effective lipids and method for producing organ-/tissue-specific therapeutically effective lipids
#1045USE OF SIMPLE AMINO ACIDS TO FORM POROUS PARTICLES
#1046USE OF SIMPLE AMINO ACIDS TO FORM POROUS PARTICLES
#1047PHARMACEUTICALLY ACCEPTABLE PHOSPHATE-GLYCEROL CARRYING BODIES
#1048Use of lecithin as a medication for the treatment of psoriasis
#1049Method for reducing the severity of neurological disorders
#1050Low viscosity liquid dosage forms
#1051METHOD FOR PREPARATION OF POLYUNSATURATED FATTY ACID-CONTAINING PHOSPHATIDYLSERINE
#1052Particle Enhancement Agent For High Intensity Focused Ultrasound Treatment And Use Thereof
#1053Fluoro-Carbon Emulsion Enhancement Agent for High Intensity Focused Ultrasound Treatment and Use thereof
#1054Compounds for the treatment of psychiatric or substance abuse disorders
#1055APOPTOSIS-MIMICKING SYNTHETIC ENTITIES AND USE THEREOF IN MEDICAL TREATMENT
#1056Use of lipid conjugates in the treatment of diseases or disorders of the eye
#1057Contact lens compositions
#1058Food Composition For Rapidly Attenuating Inflammatory Responses
#1059Formulations containing alkylphosphocholines using novel negative charge carriers
#1060Lipids containing omega-3 and omega-6 fatty acids
#1061LIPIDS CONTAINING OMEGA-3 AND OMEGA-6 FATTY ACIDS
#1062PHARMACEUTICALLY ACCEPTABLE PHOSPHATE-GLYCEROL CARRYING BODIES
#1063Infant Formulas for Early Brain Development
#1064Novel applications of omega-3 rich phospholipids
#1065Anti-inflammatory properties of marine lipid compositions
#1066MIXTURES OF AND METHODS OF USE FOR POLYUNSATURATED FATTY ACID-CONTAINING PHOSPHOLIPIDS AND ALKYL ETHER PHOSPHOLIPIDS SPECIES
#1067Lung Surfactant Supplements
#1068Method for treating proliferative disorders with HSP90 inhibitors
#1069Infant formulas for early brain development
#1070Inflammation and Oxidative Stress Reducing Compostion for Topical or Oral Administration
#1071MULTI-CAROTENOIDS COMPOSITIONS AND USES THEREFOR
#1072COMPOSITION AND METHOD FOR TREATING PATIENTS WITH HIGH NEUROTRANSMITTER LEVELS
#1073Method of Modulating Pro-Inflammatory and Inflammatory Activity Mediated by C-Reactive Protein
#1074Mucosal formulation
#1075Strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it
#1076Compositions for regulating intestinal disorders and methods of use thereof
#1077Compositions for regulating metabolic disorders and methods of use thereof
#1078Diet supplement for causing rapid weight loss, controlling appetite, managing stress, supporting relaxation, combating fatigue and supporting mental well-being.
#1079Apoptosis-mimicking synthetic entities and use thereof in medical treatment
#1080Dispersion for pulmonary delivery of a bioactive agent
#1081Preparation for the prevention and/or treatment of vascular disorders
#1082Use of 13-HODE as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
#1083Methods for the Treatment of Macular Degeneration and Related Eye Conditions
#1084Methods for preparing oil bodies comprising active ingredients
#1085Enteral composition for the prevention and/or treatment of sepis
#1086Stabilized formulations of phosphatidylserine
#1087Protection of female reproductive system from natural and artifical insults
#1088Use of lipid conjugates in the treatment of conjunctivitis
#1089Compositions and methods for the treatment and prevention of fibrotic, inflammatory and neovascularization conditions
#1090Use of peroxisome proliferator-activated receptor gamma (ppary) and/or retinoic acid receptor (rxr) agonists to inhibit platelet functions
#1091METHOD TO REDUCE OXIDATIVE DAMAGE AND IMPROVE MITOCHONDRIAL EFFICIENCY
#1092Treatment and prevention of asthma
#1093Pharmaceutical compositions for the administration of aptamers
#1094Compositions to improve the bioavailability of polymethoxyflavones and tocotrienols for treatment of cardiovascular disease
#1095Pharmaceutical compositions for the administration of aptamers
#1096Phospholipid gel compositions for delivery of aptamers and methods of treating conditions using same
#1097Lipid analogs for inhibiting HIV-1 activity
#1098Lipid analogs for inhibiting the activity of hepatitis B antigen
#1099Use of simple amino acids to form porous particles
#1100Lipid analogs for combating tumors
#1101Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders
#1102Krill extracts for treatment of cardiovascular diseases
#1103Immunostimulant composition comprising at least one toll-like receptor 7 or toll-like receptor 8 agonist and a toll-like receptor 4 agonist
#1104Lipid compositions and methods of use
#1105LPA2 receptor agonist inhibitors of CFTR
#1106Use of lipid conjugates in the treatment of disease
#1107Treatment of inflammation and vascular abnormalities of the eye
#1108Use of phospholipid arachidonic acids for increasing muscle mass in humans
#1109Lipids from methanotrophic bacteria for cholesterol reduction
#1110Modulation of Epac, phospholipase Cepsilon, and phospholipase D to treat pain
#1111Method for treatment or prevention of conditions caused by gram-positive bacteria
#1112Medical cosmetic method for reducing adipose tissue and for initiating lipolysis through subcutaneous and intracutaneous injections and customized composition compounded from pharmaceutical agents for use therein
#1113Compositions containing phosphatidylcholine and essential fatty acids
#1114Lipid-containing compositions and methods of using them
#1115Use of phospholipid arachidonic acids for increasing muscle mass in humans
#1116PRODUCTS FOR TOPICAL APPLICATION COMPRISING LYSOPHOSPHOLIPIDS AND FATTY ACIDS
#1117Enhanced delivery of sphingolipids
#1118Compositions and methods for emulsifying a pefluorocarbon with an oxygen-carrying surfactant
#1119Composition comprising protein material and compounds comprising non-oxidizable fatty acid entities
#1120Dietary supplement for enhancing skeletal muscle mass, decreasing muscle protein degradation, downregulation of muscle catabolism pathways, and decreasing catabolism of muscle cells
#1121Phospholipid formulations and uses thereof in lung disease detection and treatment
#1122Composition comprising plant and/or fish oils and compounds comprising non-oxidizable fatty acid entities
#1123Physiologically active composition based on phosphatidylserine
#1124Production and use of a polar lipid-rich fraction containing stearidonic acid and gamma linolenic acid from plant seeds and microbes
#1125Methods and compositions for treating Parkinson's disease
#1126Use of lipid conjugates in the treatment of disease
#1127Diet supplement for causing rapid weight loss, controlling appetite, managing stress, supporting relaxation, combating fatigue and supporting mental well-being
#1128Diet supplements for causing fast weight loss, improving daytime energy, promoting nighttime relaxation and sleep, controlling appetite and/or increasing metabolism
#1129Pulmonary surfactant formulations
#1130Pharmaceutical compositions for treating or preventing coronary artery disease
#1131Methods for the treatment and prevention of angiogenic diseases
#1132Methods for the treatment and prevention of inflammatory diseases
#1133Pharmaceutical composition comprising PIM-activated NKT cells, and use thereof in therapy
#1134Composition and method for reducing the appearance of cellulite
#1135Absorption of fat-soluble nutrients
#1136A COMBINATION OF MITOCHONDRIAL NUTRIENTS FOR RELIEVING STRESS, PREVENTING AND IMPROVING STRESS-RELATED DISORDERS
#1137Methods of treating cancer with lipid-based platinum compound formulations administered intraperitoneally
#1138Glycerophospholipids containing omega-3 and omega-6 fatty acids and their use in the treatment and improvement of cognitive functions
#1139Vitamin E phosphate/phosphatidylcholine liposomes to protect from or ameliorate cell damage
#1140INJECTABLE PHOSPHATIDYLCHOLINE PREPARATIONS
#1141Wound treatment utilizing collagenase and a phosphotidylcholine organogel
#1142Charged lipoprotein complexes and their uses
#1143Athlete dietary supplement
#1144Choline esters useful for the treatment of cognitive dysfunctions and enhancement of memory, learning and cognition
#1145Methods and compositions using oxidized phospholipids
#1146Methods and apparatus for creating particle derivatives of HDL with reduced lipid content
#1147Sphingoid polyalkylamine conjugates for Hepatitis B virus vaccination
#1148Compositions and methods for the treatment and prevention of hyperproliferative diseases
#1149Fatty acid composition for treatment of alzheimer's disease and cognitive dysfunction
#1150Composition comprising phytosphingosine derivatives for apoptosis induction
#1151Compositions for delivery of drug combinations
#1152Pulmonary delivery particles comprising water insoluble or crystalline active agents
#1153Method of plasma lipidation to prevent, inhibit and/or reverse atherosclerosis
#1154Pulmonary delivery particles with phospholipid structural matrix
#1155Drug formulations having long and medium chain triglycerides
#1156Lipids
#1157Breast health supplement and detoxification preparations
#1158Method and dietary composition for improving lipid digestibility
#1159Charged phospholipid compositions and methods for their use
#1160Methods and related compositions for reduction of fat and skin tightening
#1161Eye care kit for treating periocular disease
#1162Multiple sclerosis treatment
#1163AWAT-related methods and articles
#1164Purified phospholipid-non-steroidal anti-inflammatory drug associated compositions and methods for preparing and using same
#1165Method of inducing apoptosis and inhibiting cardiolipin synthesis
#1166Compositions containing uridine and choline, and methods utilizing same
#1167Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof
#1168Cationic antiseptic compositions and methods of use
#1169Combination of unsaponifiable lipids combined with polyphenols and/or catechins for the protection, treatment and repair of cartilage in joints of humans and animals
#1170Uridine effects on dopamine release
#1171Method of skin care and/or treatment using extracts enriched in mitochondria
#1172Apoprotein cochleate compositions
#1173Anti-inflammatory compositions for treating multiple sclerosis
#1174Dietary supplements containing extracts of cinnamon and methods of using same to promote weight loss
#1175Modulation of lysophosphatidylcholine and treatment of diet-induced conditions
#1176Therapeutic use of agonist ligands specific to G2A receptor
#1177Therapeutic micro nutrient composition for lipolysis and drug delivery
#1178Phospholipid compositions and methods for their preparation and use
#1179Treatment for dark adaptation
#1180Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
#1181Omega-3 fatty acids in the treatment of depression
#1182Methods and related compositions for reduction of fat
#1183Method of improving absorption of vitamin E by a pet animal
#1184Compositions for improving mental performance
#1185Stabilized pure vitamin-C in powder to liquid form using multi-encapsulation method
#1186Methods and compositions for improving photodynamic therapy through administration of lipids
#1187Breast health preparations
#1188Polypeptoid pulmonary surfactants
#1189Esterified fatty acid composition
#1190Compositions for elastogenesis and connective tissue treatment
#1191Uridine administration improves phosphatide synthesis, synaptic transmission and cogntive function
#1192Phospholipids for the treatment of infection by togaviruses, herpes viruses and coronaviruses
#1193Methods and compositions for the treatment of respiratory syncytial virus
#1194Pharmaceutical compositions of safingol and methods of using the same
#1195Uridine administration improves phosphatide synthesis, synaptic transmission and cognitive function
#1196Use of phospholipids in peritoneal dialysis
#1197Uridine administration stimulates membrane production
#1198Preparation of highly polyunsaturated fatty acid-containing phosphatidylserine and phosphatidic acid
#1199Peptide-carrying bodies for immune response
#1200Method and dietary composition for improving fat digestibility